Medifast stock hits 52-week low at $14.88 amid sharp decline

Published 12/02/2025, 16:12
Medifast stock hits 52-week low at $14.88 amid sharp decline

In a challenging year for Medifast (NYSE:MED) Inc., the company’s stock has tumbled to a 52-week low, with shares dropping to $14.88. According to InvestingPro analysis, the company appears undervalued at current levels, despite maintaining strong financial health with a current ratio of 3.11. This latest price level reflects a significant downturn for the health and wellness brand, which has seen its stock value erode by -71.63% over the past year. While investors have been wary as the company grapples with market pressures and internal challenges, Medifast maintains impressive gross profit margins of 73.8% and trades at an attractive price-to-book ratio of 0.78. The 52-week low serves as a critical marker for Medifast, as stakeholders and analysts reassess the company’s strategies and outlook for recovery in a competitive industry. InvestingPro subscribers can access 13 additional key insights and a comprehensive Pro Research Report that provides deep-dive analysis of Medifast’s financial health and future prospects.

In other recent news, Medifast, a health and wellness company, has garnered attention with the launch of a high-protein, fiber-rich mini meals and a daily nutrient pack. These new products are specifically tailored to the needs of individuals on GLP-1 medications and those seeking assistance in weight maintenance. The new product line is a testament to Medifast’s ongoing commitment to health and wellness solutions. The market responded positively to these developments, as evidenced by a rise in Medifast’s shares by up to 4.9%. It’s important to note these are recent developments and the long-term impact on the company’s performance remains to be seen.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.